Understanding the risks and benefits of current im
分类： Pediatrics-儿科杂志
公开支持基于证据的疫苗接种时间表
Speak out to support evidence-based vaccine schedu
认识一些疫苗可预防的疾病
Recognizing a Few of the Vaccine Preventable Disea
医学博士 Tina Tan 对佛罗里达州寻求取消所有疫苗要求做出反应
Tina Tan, MD, reacts to state of Florida seeking e
2025 年 4 月 ACIP 会议更新：流感、COVID-19、HPV、RSV 和其他免疫接种
April 2025 ACIP Meeting Update: Influenza, COVID-1
儿童人偏肺病毒与呼吸道合胞病毒的比较分析
Human Metapneumovirus and Respiratory Syncytial Vi
癌症儿童对 COVID-19 疫苗接种的免疫反应
Immune Response to COVID-19 Vaccination in Childre
COVID 后的呼吸道感染和其他感染
Respiratory and Other Infections Following COVID 信
接种第二剂含麻疹疫苗后免疫性血小板减少症复发的风险
Risk of Immune Thrombocytopenic Purpura Recurrence
尼塞维单抗对婴儿呼吸道合胞病毒（RSV）及 RSV 相关事件的有效性
Effectiveness of Nirsevimab Against RSV and RSV-Re
0至23月龄呼吸道合胞病毒感染住院儿童的特征
Characteristics of Children Aged 0 to 23 Months Ho
关于预防婴幼儿呼吸道合胞病毒感染的建议：政策声明
Recommendations for the Prevention of RSV Disease
低剂量类固醇对严重小儿肺炎支原体肺炎有效
Low-dose steroid effective for severe pediatric My
报告：患有严重 RSV 的儿童比患有 HMPV 的儿童住院风险更高
Report: Kids with severe RSV at higher risk for ho
针对呼吸道合胞病毒感染住院高风险婴幼儿的帕利珠单抗预防
Palivizumab Prophylaxis in Infants and Young Child
针对呼吸道合胞病毒感染住院高风险婴幼儿的帕利珠单抗预防更新指南
Updated Guidance for Palivizumab Prophylaxis Among